A new global study led by UNSW Sydney shows the use of antipsychotics during pregnancy bears little to no increased risk of a child developing neurodevelopmental disorders or learning difficulties, including ADHD and autism.
The findings offer assurance to expecting mothers who are concerned about continuing their medications, which are used to treat a variety of mental health conditions.
The above article was sent to subscribers in Pharmacy Daily's issue from 18 Mar 24
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 18 Mar 24
